update
DSM’s says CMO sales up in Q1, but predicts challenging 2012
DSM saw some improvement for its CMO business in Q1 2012, but says the market will continue to be a challenge.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs